- American Society of Hematology - Hematology. org
As the world’s largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases, ASH is fighting for hematology in the face of executive orders and other federal actions that threaten hematology research and, ultimately, the care of patients
- 4 notable presentations from ASH 2025 - MD Anderson Cancer Center
At the 2025 American Society of Hematology (ASH) Annual Meeting and Exposition, they are sharing their latest research with colleagues from across the globe Here are four of their latest advances that are being presented at ASH 2025
- 15 Posts Not to Miss from ASH 2025, Part 1 - OncoDaily
The 67th American Society of Hematology (ASH) Annual Meeting Exposition will take place from December 6–9, 2025, in Orlando, Florida, offering both in-person and virtual participation
- Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
Key Takeaways The ASH Annual Meeting will showcase new therapies, emerging data, and scientific insights in hematology, with a focus on multiple myeloma, leukemia, and sickle cell disease Pharmacy Times will report on late-breaking abstracts, clinical trial findings, and new research, including interviews with leading hematologist-oncologists Key topics include minimal residual disease
- Urban Ash Contains Harmful Toxins From CA Fires | Weather. com
Urban ash from the California wildfires that has settled across the state has now been found more than 100 miles offshore Scientists worry that this toxic ash, which contains materials such as
- Research highlights from ASH 2025 conference | STATus Report
Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference
- ASH Clinical News | American Society of Hematology
This installment of Drawing First Blood highlights a recent ASH Clinical News webinar, moderated by editor-in-chief Aaron Gerds, MD During the webinar, Jonathon Cohen, MD, MS, and Joshua Brody, MD, discussed some of the questions surrounding MCL treatment strategies
- ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
ASH now runs the Center for Sickle Cell Disease Initiatives, which launched in 2015, and the disease was the topic of several special interest sessions at this year’s meeting
|